Plasma exchange has been reported to be efficacious in chronic inflammatory demyelinating polyradiculoneuropathy. We performed a prospective double-blind trial in which patients with static or worsening disease were randomly assigned to plasma exchange (n = 15) or to sham exchange (n = 14) for three weeks. After three weeks, we observed statistically significant differences in combined measurements of nerve conduction (total, motor, proximal, velocity, and amplitude) favoring patients who had received plasma exchange. Improvement to a greater degree than for any patient receiving sham exchange was detected in the neurologic-disability score in five patients (P = 0.025) and in subset scores for weakness and reflex in four patients (P less than 0.057). We conclude that for some patients with chronic inflammatory demyelinating polyradiculoneuropathy, plasma exchange has an ameliorating effect on neurologic dysfunction and nerve conduction, but in others no improvement is observed. Because plasma was replaced with normal serum albumin, a humoral factor or factors may have a role in the neurologic deficit of this disorder.
This article has been cited by other articles:
Muley, S. A., Kelkar, P., Parry, G. J.
(2008). Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With Pulsed Oral Steroids. Arch Neurol
65: 1460-1464
[Abstract][Full Text]
Dyck, P. J., Norell, J. E., Tritschler, H., Schuette, K., Samigullin, R., Ziegler, D., Bastyr, E. J. III, Litchy, W. J., O'Brien, P. C.
(2007). Challenges in Design of Multicenter Trials: End points assessed longitudinally for change and monotonicity. Diabetes Care
30: 2619-2625
[Abstract][Full Text]
Lehmann, H. C., Hartung, H.-P., Hetzel, G. R., Stuve, O., Kieseier, B. C.
(2006). Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders.. Arch Neurol
63: 1066-1071
[Abstract][Full Text]
Odaka, M, Tatsumoto, M, Susuki, K, Hirata, K, Yuki, N
(2005). Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin. J. Neurol. Neurosurg. Psychiatry
76: 1115-1120
[Abstract][Full Text]
Natarajan, N., Weinstein, R.
(2005). Therapeutic Apheresis in Neurology Critical Care. J Intensive Care Med
20: 212-225
[Abstract]
Van Asseldonk, J. T. H., Van den Berg, L. H., Kalmijn, S., Wokke, J. H. J., Franssen, H.
(2005). Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37{degrees}C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Brain
128: 880-891
[Abstract][Full Text]
Lopate, G., Pestronk, A., Al-Lozi, M.
(2005). Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With High-Dose Intermittent Intravenous Methylprednisolone. Arch Neurol
62: 249-254
[Abstract][Full Text]
Burns, T. M.
(2004). Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Arch Neurol
61: 973-975
[Abstract][Full Text]
Ropper, A. H.
(2003). Current treatments for CIDP. Neurology
60: S16-22
[Abstract][Full Text]
Koski, C. L.
(2002). Therapy of CIDP and related immune-mediated neuropathies. Neurology
59: S22-27
[Abstract][Full Text]
Pittock, S. J., Meldrum, D., Hardiman, O.
(2002). The "Spray Can" Sign: Validation of a Clinical Observation in Chronic Inflammatory Demyelinating Polyneuropathy. Arch Neurol
59: 1637-1640
[Abstract][Full Text]
Benatar, M., Mendell, J. R.
(2001). Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology
57: 938-938
[Full Text]
Hvas, A.-M., Ellegaard, J., Nexo, E.
(2001). Vitamin B12 Treatment Normalizes Metabolic Markers But Has Limited Clinical Effect: A Randomized Placebo-controlled Study. Clin. Chem.
47: 1396-1404
[Abstract][Full Text]
Hvas, A.-M., Ellegaard, J., Nexo, E.
(2001). Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency. Arch Intern Med
161: 1534-1541
[Abstract][Full Text]
Mendell, J.R., Barohn, R.J., Freimer, M.L., Kissel, J.T., King, W., Nagaraja, H.N., Rice, R., Campbell, W.W., Donofrio, P.D., Jackson, C.E., Lewis, R.A., Shy, M., Simpson, D.M., Parry, G.J., Rivner, M.H., Thornton, C.A., Bromberg, M.B., Tandan, R., Harati, Y., Giuliani, M.J.
(2001). Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology
56: 445-449
[Abstract][Full Text]
Periquet, M. I., Novak, V., Collins, M. P., Nagaraja, H. N., Erdem, S., Nash, S. M., Freimer, M. L., Sahenk, Z., Kissel, J. T., Mendell, J. R.
(1999). Painful sensory neuropathy: Prospective evaluation using skin biopsy. Neurology
53: 1641-1641
[Abstract][Full Text]
Cornblath, D. R., Chaudhry, V., Carter, K., Lee, D., Seysedadr, M., Miernicki, M., Joh, T.
(1999). Total neuropathy score: Validation and reliability study. Neurology
53: 1660-1660
[Abstract][Full Text]
Clark, W. F., Rock, G. A., Buskard, N., Shumak, K. H., LeBlond, P., Anderson, D., Sutton, D. M., for the Canadian Apheresis Group*,
(1999). Therapeutic Plasma Exchange: An Update from the Canadian Apheresis Group. ANN INTERN MED
131: 453-462
[Abstract][Full Text]
Mariette, X., Chastang, C., Louboutin, J.-P., Leger, J.-M., Clavelou, P., Brouet, J.-C.
(1997). A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. J. Neurol. Neurosurg. Psychiatry
63: 28-34
[Abstract][Full Text]
